Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial to Compare Effectiveness of 4 Months Rifampin (4 RIF) With 9 Months Isoniazid (9 INH) in the Prevention of Active TB in Children: The P4v9 Trial

NCT00170209 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT00170209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00170209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial to Compare Effectiveness of 4 Months Rifampin (4 RIF) With 9 Months Isoniazid (9 INH) in the Prevention of Active TB in Children: The P4v9 Trial
Lead sponsor
McGill University
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2011
Completion date
May 31, 2015
Enrollment
844 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

latent tuberculosis infection